Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06866379

Involvement of the Septal Nuclei of the Human Brain in Alcohol Use Disorder

Involvement of the Septal Nuclei of the Human Brain in Alcohol Use Disorder - a Functional Magnetic Resonance Imaging Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Anders Fink-Jensen, MD, DMSci · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Alcohol activates reward systems in different brain areas, i.e., the nucleus accumbens, dorsal striatum, extended amygdala, and prefrontal cortex. These areas are all part of the reward neurocircuitry, which plays an important role in the development of addiction. A former study performed on rodents has shown that a specific area of the forebrain, the septal nuclei, is associated with the feeling of reward and, hence, addiction when stimulated. However, whether the septal area is involved in reward and addiction in humans is sparsely investigated. The purpose of this brain-imaging study is to assess how the septal nuclei react to alcohol-related pictures shown to participants diagnosed with alcohol use disorder while lying in an MRI scanner, compared to people without a diagnosis of alcohol use disorder. This might give us a better understanding of how the septal nuclei is involved in reward and addiction.

Detailed description

This is a comparative, non-interventional, case-control, brain imaging study using the ALCUE paradigm to investigate the neuro-anatomical underpinings of AUD during a fMRI-scan. The contrast used for the fMRI scans is the BOLD signal which measures the ratio of oxygenated to deoxygenated blood in the brain as a measurement of neural activity. The study will conclude after the last participant with AUD succesfully has undergone the fMRI scan, and will include 50 participants in total: 25 participants diagnosed with AUD and 25 participants without AUD (data from a previous brain imaging study). Written informed consent will be collected, before any trial activities are performed.

Conditions

Interventions

TypeNameDescription
OTHERBrain imagingfMRI session with the ALCUE paradigme.

Timeline

Start date
2025-05-07
Primary completion
2025-09-01
Completion
2025-11-30
First posted
2025-03-10
Last updated
2025-06-11

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06866379. Inclusion in this directory is not an endorsement.